Graph-Based Machine Learning for Predicting Drug–Drug Interactions: A Systematic Review
Pharmaceuticals · 04.08.2026 · 19 (8) · 1225
DOI: 10.3390/ph19081225 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 04.08.2026. Verfasst von Md Tuhin Reza und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science & Engineering, Jashore University of Science & Technology, Jashore 7408, Bangladesh. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Drug–drug interactions (DDIs) are major medication-safety concerns, and experimental testing cannot cover the expanding number of drug pairs. This systematic review evaluates graph-based machine-learning methods for DDI prediction, focusing on machine-learning architectures, data integration, interpretability, reproducibility, and clinical relevance.
Methods
Following PRISMA 2020, we systematically searched major databases for studies published between January 2021 and March 2026. We included studies that applied graph-based machine-learning models, particularly graph neural networks, to predict DDIs. We compared their data sources, model designs, validation methods, predictive performance, reproducibility, and clinical relevance. Because the studies used different datasets and evaluation methods, the findings were summarized narratively rather than combined statistically.
Results
Sixty studies met the eligibility criteria. Methods progressed from graph convolutional networks and graph attention networks to graph transformers, contrastive learning, multimodal fusion, and LLM-enhanced representations. We found that reported improvements in prediction performance often remained study-specific. Only three studies explicitly mentioned or addressed data leakage, whereas most reviewed studies contained no explicit leakage discussion; leakage-aware drug-disjoint, temporal, and external evaluations were also uncommon. Uncertainty calibration, computational-resource reporting, complete reproducibility materials, and independently validated explanations were also limited.
Conclusions
Graph-based machine learning is promising for DDI prioritization and hypothesis generation but remains insufficient for independent clinical decision-making. Future studies should use standardized benchmarks, leakage-aware validation, calibrated uncertainty, reproducible pipelines, validated explanations, and external or prospective evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer Science & Engineering, Jashore University of Science & Technology, Jashore 7408, Bangladesh.
- Department of Software Engineering, Daffodil International University, Daffodil Smart City, Dhaka 1216, Bangladesh.
- Computer Science, University of Artois, 62000 Arras, France.
- ICT Division, Bangladesh Bureau of Educational Information & Statistics (BANBEIS), Dhaka 1207, Bangladesh.
ORCID-Profile: Md Tuhin Reza, Md Abdul Kader, Wissem Inoubli, Md Biddut Hossain, Md Kamrul Islam
Zitieren
APA
Reza, M. T., Kader, M. A., Inoubli, W., Hossain, M. B., & Islam, M. K. (2026). Graph-Based Machine Learning for Predicting Drug–Drug Interactions: A Systematic Review. Pharmaceuticals, 19(8), 1225. https://doi.org/10.3390/ph19081225
Vancouver
Reza MT, Kader MA, Inoubli W, Hossain MB, Islam MK. Graph-Based Machine Learning for Predicting Drug–Drug Interactions: A Systematic Review. Pharmaceuticals. 2026;19(8):1225. doi:10.3390/ph19081225
BibTeX
@article{Reza2026,
author = {Reza, Md Tuhin and Kader, Md Abdul and Inoubli, Wissem and Hossain, Md Biddut and Islam, Md Kamrul},
title = {Graph-Based Machine Learning for Predicting Drug–Drug Interactions: A Systematic Review},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {8},
pages = {1225},
doi = {10.3390/ph19081225}
}
EUVIMED